Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: ‘We’re making progress’

Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: ‘We’re making progress’

Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…

Weekend read: Top stories of the week in Health in case you missed them

Weekend read: Top stories of the week in Health in case you missed them

Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a…

End of content

End of content